iScience (Dec 2022)

Survivin promotes a glycolytic switch in CD4+ T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis

  • Malin C. Erlandsson,
  • Karin M.E. Andersson,
  • Nina Y. Oparina,
  • Venkataragavan Chandrasekaran,
  • Tibor Saghy,
  • Anastasios Damdimopoulos,
  • Maria-Jose Garcia-Bonete,
  • Zakaria Einbeigi,
  • Sofia T. Silfverswärd,
  • Marcela Pekna,
  • Gergely Katona,
  • Maria I. Bokarewa

Journal volume & issue
Vol. 25, no. 12
p. 105526

Abstract

Read online

Summary: In this study, we explore the role of nuclear survivin in maintaining the effector phenotype of IFNγ-producing T cells acting through the transcriptional control of glucose utilization. High expression of survivin in CD4+T cells was associated with IFNγ-dependent phenotype and anaerobic glycolysis. Transcriptome of CD4+ cells and sequencing of survivin-bound chromatin showed that nuclear survivin had a genome-wide and motif-specific binding to regulatory regions of the genes controlling cell metabolism. Survivin coprecipitates with transcription factors IRF1 and SMAD3, which repressed the transcription of the metabolic check-point enzyme phosphofructokinase 2 gene PFKFB3 and promoted anaerobic glycolysis. Combining transcriptome analyses of CD4+ cells and functional studies in glucose metabolism, we demonstrated that the inhibition of survivin reverted PFKFB3 production, inhibited glucose uptake, and reduces interferon effects in CD4+ cells. These results present a survivin-dependent mechanism in coordinating the metabolic adaptation of CD4+T cells and propose an attractive strategy to counteract IFNγ-dependent inflammation in autoimmunity.

Keywords